Formation of novel 1,3-thiazole- and 1,2-thiazole-fused aporphines
395
Off-white plate shape crystals, Rf (chloroform:metha-
nol = 8:2) 0.59; m.p. 162–164 °C; yield: 188 mg (39%);
[a]D25 –206 cm2 g-1 (c 0.1, chloroform); HR-MS (ESI) m/
z (%) found: 415.1479 (M++1, 100), calculated: 415.1484
and coupling constants (J) are measured in Hz. Signal
assignments were based on standard APT, DEPT, HSQC,
HMQC, 1H–1H COSY and NOESY experiments. High-
resolution mass spectral measurements were performed
with a Bruker micrOTOF-Q instrument in the ESI (elec-
trospray ionization) mode. Optical rotation was determined
with a Perkin Elmer Model 241 polarimeter. Elemental
analyses (C, H, N, S) were conducted using the Elemental
Analyser Carlo Erba 1106; their results were found to be in
good agreement ( 0.2%) with the calculated values.
The microwave-induced reactions were carried out in a
Discover model microwave reactor manufactured by CEM
Corporation. Controlled temperature, power, pressure and
time settings were used for all reactions.
1
(M++1); H NMR (360 MHz, CDCl3): d = 7.91 (s, H1),
7.77–7.19 (m, 5H, 3-Ph), 6.68 (2d, J9–10 7.7 Hz, H9, H10),
6.12 (br s, 12-OH), 3.83 (s, 11-OCH3), 3.09–2.41 (m, H5a,
H6a, H6b, H7a), 2.38 (s, NCH3), 2.30–2.07 (m, H5b, H8a,
H8b) ppm; 13C NMR (90 MHz, CDCl3): d = 166.7 (C3),
154.2 (C10), 149.1 (C11), 142.7 (C12), 135.4–112.1 (Ar,
15C), 59.0 (OCH3), 56.5 (C7a), 52.8 (C6), 41.2 (NCH3),
35.1 (C8), 27.4 (C5) ppm.
(7aR)-3-Amino-12-hydroxy-11-methoxy-thiazolo[4,5-k]-5,
6, 7a, 8-tetrahydro-4H-dibenzo [de,g]quinoline (8)
(20-aminothiazolo-apocodeine)
Acid-catalyzed rearrangement of morphinandienes
(general procedure)
Pale yellow cubic crystals were obtained by the recrystal-
lization of crude apocodeine from anhydrous ether; m.p.
25
109–111 °C (ether); yield: 488 mg (89%); [a]D
A mixture of the diene (1 g) and methanesulfonic acid
(5 cm3) was stirred for 20 min at 0 °C. Then the reaction
mixture was heated at 90–95 °C for 30 min. After cooling
to room temperature, the product mixture was added
dropwise, with stirring and external ice-cooling, to a
solution of potassium hydrogen carbonate (10 g) in water
(50 cm3). After extraction with chloroform (3 9 15 cm3),
the combined extracts were washed with saturated brine,
dried (MgSO4), and concentrated in vacuum. In case of
necessity, the residue was submitted to purification by
means of column chromatography (Kieselgel 40, chloro-
form:methanol = 1:1) to yield appropriate apocodeines.
-203 cm2 g-1 (c 0.1, methanol); HR-MS (ESI) m/z (%)
found: 354.1261 (M++1, 100), calculated: 354.1274
(M++1); 1H NMR (360 MHz, DMSO-d6): d = 8.87 (s,
12-OH), 8.29 (s, H1), 7.41 (s, 3-NH2), 6.82 (2d, J9-10
8.4 Hz, H9, H10), 3.84 (s, 11-OCH3), 3.31-2.78 (m, H5a,
H6a, H6b, H7a), 2.47 (s, NCH3), 2.66–2.09 (m, H5b, H8a,
H8b) ppm; 13C NMR (90 MHz, DMSO-d6): d = 162.9
(C3), 148.3 (C10), 148.1 (C11), 143.4 (C12), 135.2–114.5
(Ar, 9C), 60.3 (C7a), 56.4 (OCH3), 52.4 (C6), 42.4 (NCH3),
35.8 (C8), 28.8 (C5) ppm.
(7aR)-12-Hydroxy-2-methyl-11-methoxy-isothiazolo[4,5-
k]-5, 6, 7a, 8-tetrahydro-4H-dibenzo [de,g]quinoline (9)
(30-methylisothiazolo-apocodeine)
(7aR)-12-Hydroxy-3-methyl-11-methoxy-thiazolo[4,5-k]-5,
6, 7a, 8-tetrahydro-4H-dibenzo [de,g]quinoline (6)
(20-methylthiazolo-apocodeine)
Column chromatography was applied to separate com-
pounds 6 and 9. Compound 9 was the second eluted
fraction. Grey plate shape crystals, Rf (chloroform:meth-
anol = 8:2) 0.44; m.p. 142–147 °C, yield: 167 mg (44%);
Column chromatography was applied to separate com-
pounds 6 and 9. Compound 6 was the first eluted fraction.
Grey plate shape crystals; Rf (chloroform:methanol = 8:2)
25
[a]D +16 cm2 g-1 (c 0.1, chloroform); HR-MS (ESI)
25
0.67; m.p. 170–173 °C; yield: 216 mg (44%); [a]D
m/z (%) found: 353.1315 (M++1, 100), calculated:
353.1321 (M++1); 1H NMR (360 MHz, CDCl3):
d = 7.98 (s, H1), 6.77 (2d, J9–10 7.9 Hz, H9, H10), 6.44
(br s, 12-OH), 3.92 (s, 11-OCH3), 3.52–2.83 (m, H5a,
H5b, H6b, H7a, H8b), 2.60 (s, 2-CH3), 2.55 (m, H8a), 2.51
(s, NCH3), 2.41 (m, H6a) ppm; 13C NMR (90 MHz,
CDCl3): d = 158.7 (C2), 147.9 (C11), 142.9 (C12), 142.7
(C5a), 138.2 (C4a), 133.8–114.6 (Ar, 8C), 60.6 (C7a), 56.4
(OCH3), 52.1 (C6), 41.2 (NCH3), 34.0 (C8), 23.8 (C5),
19.5 (C-CH3) ppm.
–109 cm2 g-1 (c 0.1, chloroform); HR-MS (ESI) m/z (%)
found: 353.1309 (M++1, 100), calculated: 353.1321
(M++1); H NMR (360 MHz, CDCl3): d = 7.95 (s, H1),
1
6.77 (2d, J9–10 7.2 Hz, H9, H10), 6.71 (br s, 12-OH), 3.92
(s, 11-OCH3), 3.52-2.92 (m, H5a, H6a, H6b, H7a), 2.85 (s,
3-CH3), 2.81–2.51 (m, H5b, H8a, H8b, NCH3) ppm; 13C
NMR (90 MHz, CDCl3): d = 169.6 (C3), 152.9 (C10),
148.5 (C11), 142.6 (C12), 136.7–114.4 (Ar, 9C), 60.4
(OCH3), 58.6 (C7a), 53.1 (C6), 40.7 (NCH3), 35.1 (C8),
24.2 (C5), 22.2 (C-CH3) ppm.
(7aR)-12-Hydroxy-11-methoxy-3-phenyl-isothiazolo
[4,5-k]-5, 6, 7a, 8-tetrahydro-4H-dibenzo [de,g]
quinoline (10) (20-phenylisothiazolo-apocodeine)
Column chromatography was applied to separate com-
pounds 7 and 10. Compound 10 was the second eluted
(7aR)-12-Hydroxy-11-methoxy-3-phenyl-thiazolo[4,5-k]-5,
6, 7a, 8-tetrahydro-4H-dibenzo [de,g]quinoline
(7) (20-phenylthiazolo-apocodeine)
Column chromatography was applied to separate com-
pounds 7 and 10. Compound 7 was the first eluted fraction.
123